AzTrials
AzTrials

BurnsNCT05212441

ADJUNCTIVE EFFECT OF LIGHT EMITTING DIODE ON HAND GRIP STRENGTH IN BURN PATIENTS

A study testing Light emitting diode therapy (LED therapy), Patient/family education program (Home program) and Positioning & Splinting in people with Burns and Hand Burn, run by October 6 University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will be done to evaluate effect of applying LED before hand exercise on hand grip strength. Sixty male patients with subacute partial thickness burn of hand will be randomly allocated into two equal groups of 30 patients. Read more about this study

Who is it for?
Ages 20 to 35 years
Conditions the study is for
Burns, Hand Burn, Hand Grasp
What is being tested?
Light emitting diode therapy (LED therapy), Patient/family education program (Home program) and Positioning & Splinting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
25 Feb 2022to 10 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • The subject selection will be according to the following criteria:
  • Burn caused by thermal injury (flame or scald) with involvement of the wrist and hand and other parts of the body not including shoulder and elbow.
  • Age range between 20-35 years.
  • Male gender.
  • Subacute Partial-thickness burn " From 3rd day of burn".
  • Recent discharge of in patient acute care, spontaneous healing.
  • All patients enrolled to the study will have their informed consent.

Who cannot join

  • The potential participants will be excluded if they meet one of the following criteria:
  • Cardiac diseases.
  • Perception of persistent respiratory problem related to a previous inhalation injury
  • Signs of burn infection (i.e., unclear fluid oozing from the wound, increased pain, expanded redness and swelling)
  • Exposed tendons.
  • Nerve, muscle injury.
Show all 11Show fewer
  • Scar contracture of hand.
  • Cognitive disorders.
  • Presence of fractures.
  • Patients who suffer from skin diseases, diabetes, varicose veins, and peripheral vascular diseases.
  • Patients with life threatening disorders as renal failure, myocardial infarction or other similar diseases will be excluded from the study.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • October 6 University Hospital

    Al Ḩayy Ath Thāmin, Giza Governorate, 12611

Other trials in Egypt

About this study

Official title: ADJUNCTIVE EFFECT OF LIGHT EMITTING DIODE ON HAND GRIP STRENGTH IN BURN PATIENTS: A Randomized Controlled Trial

This study will be done to evaluate effect of applying LED before hand exercise on hand grip strength. Sixty male patients with subacute partial thickness burn of hand will be randomly allocated into two equal groups of 30 patients. The following equipment and tools will be used

Measurement equipments:

  • For total active motion of fingers (TAM): Goniometer.
  • For hand grip strength: Hand grip dynamometer.

Therapeutic equipment:

Light emitting diode therapy (LED) device.

Being tested
Light emitting diode therapy (LED therapy), Patient/family education program (Home program), Positioning & Splinting, Therapeutic Exercises
Medical subject headings
Burns, Hand Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Light emitting diode therapy (LED therapy)Device

    The patient's forearm is positioned on table with palm facuing upward during the therapy. For LEDT, the center of the light spot located at approximately 50% of landmark line from the medial epicondyle to the styloid process of the ulna, which is the center belly of flexor digitorum superficialis. The subject's forearm maintained in the rest state without moving during the therapy. LED is performed before exercise.

  • Patient/family education program (Home program)Behavioural

    Patients and their families will instructed to learn the anti contracture positioning/splinting, scar massage and exercises program, application of the custom garments and inserts, and functional training to perform them on their own at home. Written and illustrative instructions and reciprocal demonstration sessions will be provided to the children and their families to ensure successful acquisition and delivery of rehabilitation skills at home program. The therapist will be reported about compliance with the home program every couple of days

  • Positioning & SplintingProcedure or surgery

    The wrist joint is splinted at 30 hyperextension, the MCP joint in 90 of flexion, the IP joints in extension, and the thumb in abduction. The webs of fingers kept in abduction. The hands are elevated above the level of the heart to minimize post-burn edema.

    Splinting: Splints are tailored to help to maintain the functional or anti-contracture position of the injured body parts.The intervals for monitoring vary from once every hour to once every 4-6 hours, depending on types of splints and skin conditions. It is described as 10 hours on and two hours off. When the splint is taken off, active and/or passive ROM should be carried out.

  • Therapeutic ExercisesOther

    1. Passive ROM (PROM).
    2. Active ROM (AROM) \& Active-assistive ROM (AAROM): The exercise will focus on extending the wrist to 45 degrees, flexing the MCP joints to 90 degrees and keeping the IP joints in full extension, while maintaining a thumb web space. The exercises will performed in the following sequences; (1) MCP joints flexion and extension with the wrist in neutral or slight extension and the IP joints in neutral position. (2) IP joints flexion to only 30-40 degrees with the wrist stabilized in the neutral or slight extension, while the MCP joints held in full extension, (3) thumb and fingers abduction and adduction, and (4) thumb opposition (tip of the thumb to tip of the small finger). Each exercise was performed for 8-10 repetition, daily, for 6 days/week.
    3. Stretching exercises: A low-load (low-intensity), long-duration stretch
    4. Strengthening exercises: done in static mode initially and progress to dynamic strengthening using elastic bands.
Study groups in NCT05212441
Study groupRoleWhat they receive
Group A (LED group)ExperimentalThis group includes 30 burned patients who will receive LED therapy in addition to their physical therapy program (splinting, stretching ex., strengthening ex. and ROM ex.) and medical treatment.
Receives: Device: Light emitting diode therapy (LED therapy); Behavioral: Patient/family education program (Home program); Procedure: Positioning & Splinting; Other: Therapeutic Exercises
Group B (Control group)Active comparatorThis group includes 30 burned patients who will receive their physical therapy program (splinting, stretching ex., strengthening ex. and ROM ex.) and medical treatment.
Receives: Behavioral: Patient/family education program (Home program); Procedure: Positioning & Splinting; Other: Therapeutic Exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Total active ROM from baseline to 6 weeks posttreatment

    Total active ROM is the sum of the active metacarpophalangeal (MP), proximal interphalangeal (PIP), and distal interphalangeal (DIP) arc of motion in degrees of an individual digit. The measurement will be performed via a hand-held finger goniometer

    Measured: baseline and 6 weeks posttreatment

  2. Changes in hand grip strength from baseline to 6 weeks posttreatment

    A calibrated hydraulic JAMAR (Model: 5030J1, Sammons Preston Rolyan, Chicago, USA), analogue hand-grip dynamometer will be used to measure grip strength. The device provides 1 kg increments on the measurement dial which faces the assessor as mentioned by Clifford et al., 2013.

    Measured: baseline and 6 weeks posttreatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2022
  2. Study start25 Feb 2022
  3. Primary completion1 Jul 2022 (estimated)
  4. Study completion10 Jul 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05212441
Sponsor's protocol ID
LEDHB2122
Status last verified
May 2022
First submitted
15 Jan 2022
Last updated
10 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Light emitting diode therapy (LED therapy), Patient/family education program (Home program) and Positioning & Splinting in people with Burns and Hand Burn, run by October 6 University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Total active ROM from baseline to 6 weeks posttreatment (time frame: baseline and 6 weeks posttreatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in